Recognized with the 15th Frontiers of Knowledge Award in Biology and Biomedicine, Demis Hassabis, pioneer in artificial intelligence and creator of AlphaFold2, explains how this tool has already transformed biological research: more than one million scientists and virtually all pharmaceutical companies use it for drug discovery. He highlights its applications in combating antibiotic resistance, seeking cures for diseases such as malaria, and creating enzymes that help reduce plastic pollution or improve crops in the face of climate change.
The BBVA Foundation Frontiers of Knowledge Award in Biology and Biomedicine has gone in this fifteenth edition to David Baker, Demis Hassabis and John Michael Jumper “for their contributions to the use of artificial intelligence for the accurate prediction of the three-dimensional structure of proteins,” in the words of the committee; an advance, it
Recognized with the 15th Frontiers of Knowledge Award in Biology and Biomedicine, Demis Hassabis, pioneer in artificial intelligence and creator of AlphaFold2, explains how this tool has already transformed biological research: more than one million scientists and virtually all pharmaceutical companies use it for drug discovery. He highlights its applications in combating antibiotic resistance, seeking cures for diseases such as malaria, and creating enzymes that help reduce plastic pollution or improve crops in the face of climate change.
The BBVA Foundation Frontiers of Knowledge Award in Biology and Biomedicine has gone in this fifteenth edition to David Baker, Demis Hassabis and John Michael Jumper “for their contributions to the use of artificial intelligence for the accurate prediction of the three-dimensional structure of proteins,” in the words of the committee; an advance, it adds, with huge biomedical potential for the development of new treatments against multiple conditions.
00:00 Introduction
00:05 How are the artificial intelligence tools developed at DeepMind, such as AlphaFold, contributing to the field of biomedical research?
00:28 What do you see as the most important biomedical applications of AlphaFold in the coming years?